Skip to main content

7 Results for “imaging”

Gore REDUCE Clinical Study Completes Enrollment

Study of Closure of Patent Foramen Ovale (PFO) in Stroke Patients Reaches Major Milestone

Feb 25, 2015

GORE RECEIVES FDA APPROVAL FOR BREAKTHROUGH ENDOVASCULAR DEVICE IN COMPLEX AORTIC ANEURYSMS

First off-the-shelf solution for treatment of complex aneurysmal disease involving the visceral aorta.

Jan 25, 2024

GORE MEDICAL RECEIVES BREAKTHROUGH DEVICE DESIGNATION FOR THE GORE® EXCLUDER® THORACOABDOMINAL BRANCH ENDOPROSTHESIS

CAUTION: Investigational device. Limited by United States law to investigational use.

Apr 12, 2022

Gore Marks Two-Year Primary Endpoint Follow-up Milestone in Study of GORE® CARDIOFORM Septal Occluder for Patent Foramen Ovale (PFO) Closure

Completion of follow -up paves way for REDUCE Clinical Study data submission to FDA for PFO indication

Mar 30, 2017

GORE® VIABAHN® Endoprosthesis Marks 20 Years of Proven Performance

Market-leading stent-graft has evolved to address range of indications, patient needs

Sep 7, 2016